Subsequently, further clinical studies in other ETEC endemic areas, as well as further in-vivo analysis are needed to evaluate if these FUT2 SNPs could be used as host biomarkers of ETEC CFA/I (and related CFA/I CFs) infection susceptibility, or vaccine efficiency of ETEC vaccine candidates containing the CFA/I antigen. Here, FUT2 is linked to infection.